These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. DichroIDP: a method for analyses of intrinsically disordered proteins using circular dichroism spectroscopy. Miles AJ; Drew ED; Wallace BA Commun Biol; 2023 Aug; 6(1):823. PubMed ID: 37553525 [TBL] [Abstract][Full Text] [Related]
44. Gas-phase conformations of intrinsically disordered proteins and their complexes with ligands: Kinetically trapped states during transfer from solution to the gas phase. Han JY; Choi TS; Heo CE; Son MK; Kim HI Mass Spectrom Rev; 2019 Nov; 38(6):483-500. PubMed ID: 31021441 [TBL] [Abstract][Full Text] [Related]
45. Compensatory adaptations of structural dynamics in an intrinsically disordered protein complex. Kurzbach D; Schwarz TC; Platzer G; Höfler S; Hinderberger D; Konrat R Angew Chem Int Ed Engl; 2014 Apr; 53(15):3840-3. PubMed ID: 24604825 [TBL] [Abstract][Full Text] [Related]
46. Probing the dynamics of disorder. Fox SJ; Kannan S Prog Biophys Mol Biol; 2017 Sep; 128():57-62. PubMed ID: 28554553 [TBL] [Abstract][Full Text] [Related]
48. Targeting disorders in unstructured and structured proteins in various diseases. Choudhary S; Lopus M; Hosur RV Biophys Chem; 2022 Feb; 281():106742. PubMed ID: 34922214 [TBL] [Abstract][Full Text] [Related]
49. The Dynamic Multisite Interactions between Two Intrinsically Disordered Proteins. Wu S; Wang D; Liu J; Feng Y; Weng J; Li Y; Gao X; Liu J; Wang W Angew Chem Int Ed Engl; 2017 Jun; 56(26):7515-7519. PubMed ID: 28493424 [TBL] [Abstract][Full Text] [Related]
50. Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration. Ayyadevara S; Ganne A; Balasubramaniam M; Shmookler Reis RJ Metab Brain Dis; 2022 Jan; 37(1):147-152. PubMed ID: 34347206 [TBL] [Abstract][Full Text] [Related]
51. New force field on modeling intrinsically disordered proteins. Wang W; Ye W; Jiang C; Luo R; Chen HF Chem Biol Drug Des; 2014 Sep; 84(3):253-69. PubMed ID: 24589355 [TBL] [Abstract][Full Text] [Related]
52. Proteus: a random forest classifier to predict disorder-to-order transitioning binding regions in intrinsically disordered proteins. Basu S; Söderquist F; Wallner B J Comput Aided Mol Des; 2017 May; 31(5):453-466. PubMed ID: 28365882 [TBL] [Abstract][Full Text] [Related]
53. Binding cavities and druggability of intrinsically disordered proteins. Zhang Y; Cao H; Liu Z Protein Sci; 2015 May; 24(5):688-705. PubMed ID: 25611056 [TBL] [Abstract][Full Text] [Related]
54. Sequence Effects on Size, Shape, and Structural Heterogeneity in Intrinsically Disordered Proteins. Baul U; Chakraborty D; Mugnai ML; Straub JE; Thirumalai D J Phys Chem B; 2019 Apr; 123(16):3462-3474. PubMed ID: 30913885 [TBL] [Abstract][Full Text] [Related]
57. Extreme Fuzziness: Direct Interactions between Two IDPs. Wang W; Wang D Biomolecules; 2019 Feb; 9(3):. PubMed ID: 30813629 [TBL] [Abstract][Full Text] [Related]
59. Caught in action: selecting peptide aptamers against intrinsically disordered proteins in live cells. Cobbert JD; DeMott C; Majumder S; Smith EA; Reverdatto S; Burz DS; McDonough KA; Shekhtman A Sci Rep; 2015 Mar; 5():9402. PubMed ID: 25801767 [TBL] [Abstract][Full Text] [Related]
60. Novel strategies for drug discovery based on Intrinsically Disordered Proteins (IDPs). Wang J; Cao Z; Zhao L; Li S Int J Mol Sci; 2011; 12(5):3205-19. PubMed ID: 21686180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]